Solvent condensation for recycling in pharmaceutical processes

Sustainability through high-efficiency solvent recovery with air refrigeration

Key information

Client:

Confidential, pharmaceutical manufacturer

Supplier:

HOF Sonderanlagenbau GmbH; Refolution Industriekälte GmbH

Type of facility:

Pharma production

System start-up:

2021

Pharmaceutical production facilities depend on a wide range of organic solvents throughout the drug development process. Reclaiming solvents significantly reduces operational costs. Beyond the pharmaceutical sector, solvent recovery is also key in chemical, petrochemical, and medical device manufacturing.

In this pharmaceutical facility, the installed CryoProPhase system recovers over 99.9% of ethanol and acetone from pharmaceutical exhaust gas, using only air as refrigerant to cool down the gas to -80 °C. By eliminating synthetic refrigerants and complying with Good Manufacturing Practices (GMP) and emission-related regulations (TA-Luft), the solution drastically reduces environmental pollution and operating costs while enabling sustainable pharmaceutical production.


Requirements

The client requested a GMP-compliant condensation of volatile organic compounds (VOCs) from exhaust gas in the production facility. The client has multiple processes with either nitrogen/ethanol or nitrogen/acetone mixtures occurring in batch processes with a high dynamic. Sudden peaks in volume flow and VOC concentration occur while the installation needed to ensure high solvent recovery with TA-Luft and environmental regulation compliance. Ideally, the recovered solvents can be used directly in the process again to avoid energy intensive recycle processes. Therefore, the ethanol and acetone sources are separated to avoid separation processes. In accordance with the clients environmental goals synthetic refrigerants (F-Gases) had to be avoided, preserving future-proof operations.


Solution

The installed CryoProPhase technology is a modular, compact cryogenic condensation skid featuring a two-pass shell-and-tube heat exchanger integrated with a centralized air- cycle refrigeration unit. The system achieves process temperatures from −40 °C to −110 °C (optionally down to −160 °C), tailored to the condensation characteristics of each solvent. Additionally, it incorporates heat recovery from waste gas to pre-cool incoming process streams, significantly reducing the net energy demand.

The system uses ambient air as refrigerant in a closed-loop turbo-compression reversed- Brayton cycle (Mirai Intex). This allows dynamic response to changing load profiles while avoiding F-gases, synthetic refrigerants, or substances subject to future bans (e.g. PFAS or TFA-producing compounds). Operating pressures remain under 10 bar, simplifying safety requirements and eliminating the need for periodic leak checks.


Key benefits and features

  • Natural refrigerant: Air with ODP =0, GWP = 0, TFA = 0

  • Modular design: Skid and chiller decoupled, allowing flexible installation

  • Dynamic performance: Turbo compressor allows fast load changes

  • Efficiency: Heat recovery and high part load performance

  • Cost-effective: Recycling, no refrigerant refill, TA-Luft compliant, low energy use

Technical data

Cooling capacity:

~5kW

Refrigerant charge:

Nitrogen gas, no phase change

Heat sink temperature

-5°C

Main components:

  • Mirai Intex air-chiller,

  • Shell‑tube cryo-exchanger

  • Heat‑recovery loop

Special features:

Figure: CryoProPhase technology

Contact

Thomas Frank

Refolution Industriekälte GmbH

info@refolution.de

+49 (0) 761 76993300

Contact

Thomas Frank

Refolution Industriekälte GmbH

info@refolution.de

+49 (0) 761 76993300